EX-99.1 2 algm-ex99_1.htm EX-99.1 EX-99.1

Exhibit 99.1

Allegro MicroSystems Reports Second Quarter 2024 Results

 

– Net Sales Increased by 16% Year-over-Year –

– GAAP & Non-GAAP EPS Increased 31% and 29% Respectively, Year-over-Year –

– Automotive Sales Increased by 31% Year-over-Year Led by E-Mobility –

Manchester, NH, November 2, 2023 – Allegro MicroSystems, Inc. (“Allegro” or the “Company”) (Nasdaq:ALGM), a global leader in power and sensing semiconductor solutions for motion control and energy efficient systems, today announced financial results for its second quarter which ended September 29, 2023.

“We delivered second quarter net sales of $276 million dollars, up 16% year-over-year, driven by continued strength in Automotive, which grew 31% year-over-year. We also achieved record non-GAAP Diluted Earnings per Share of $0.40, an increase of 29% year-over-year,” said Vineet Nargolwala, President and CEO of Allegro MicroSystems. “E-Mobility (which is the electrification of vehicles and adoption of ADAS feature sets) continues to fuel Allegro’s growth. Sales into e-Mobility applications increased by nearly 60% year-over-year to 50% of second quarter Automotive sales, establishing a new milestone.”

Second Quarter Financial Highlights:

In thousands, except per share data

 

Three-Month Period Ended

 

 

Six-Month Period Ended

 

 

September 29,
2023

 

 

June 30,
2023

 

 

September 23,
2022

 

 

September 29,
2023

 

 

September 23,
2022

 

 

 

(Unaudited)

 

 

(Unaudited)

 

 

(Unaudited)

 

 

(Unaudited)

 

 

(Unaudited)

 

Net Sales

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Automotive

 

$

205,936

 

 

$

189,698

 

 

$

157,398

 

 

$

395,634

 

 

$

307,047

 

Industrial

 

 

51,114

 

 

 

68,184

 

 

 

48,176

 

 

 

119,298

 

 

 

88,316

 

Other

 

 

18,459

 

 

 

20,411

 

 

 

32,092

 

 

 

38,870

 

 

 

60,056

 

Total net sales

 

$

275,509

 

 

$

278,293

 

 

$

237,666

 

 

$

553,802

 

 

$

455,419

 

GAAP Financial Measures

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gross margin %

 

 

57.9

%

 

 

56.8

%

 

 

55.5

%

 

 

57.3

%

 

 

55.0

%

Operating margin %

 

 

26.5

%

 

 

25.4

%

 

 

25.2

%

 

 

25.9

%

 

 

16.4

%

Diluted EPS

 

$

0.34

 

 

$

0.31

 

 

$

0.26

 

 

$

0.65

 

 

$

0.32

 

Non-GAAP Financial Measures

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gross margin %

 

 

58.3

%

 

 

57.8

%

 

 

56.2

%

 

 

58.1

%

 

 

55.6

%

Operating margin %

 

 

31.3

%

 

 

30.8

%

 

 

27.9

%

 

 

31.0

%

 

 

26.6

%

Diluted EPS

 

$

0.40

 

 

$

0.39

 

 

$

0.31

 

 

$

0.79

 

 

$

0.55

 

Business Outlook

For the third quarter ending December 29, 2023, and including two months of activity from the Crocus Technologies, Inc. acquisition which closed on October 31, 2023, the Company expects net sales to be in the range of $250 million to $260 million. The Company also estimates the following results on a non-GAAP basis:

Gross Margin is expected to be approximately 54%, reflecting lower distribution sales and the initial impact of Crocus
Operating Expenses are expected to decline 4% sequentially, and are anticipated to be approximately 28% of sales
Diluted Earnings per Share are expected to be in the range of $0.27 to $0.31

For the two-month period for which Crocus is included in the Company’s third quarter results, it is expected to add approximately $5 million to net sales, $3.5 million to interest expense, and be $0.03 dilutive to EPS.

 

Commenting on the outlook, Vineet Nargolwala said, “Our backlog remains robust. Our sales forecast reflects normal third quarter seasonality, lingering impacts from the UAW strike, heightened macroeconomic trends and elevated inventory levels in Industrial and Consumer markets. Over the mid and the long term, continued strong momentum in design wins (especially in our strategic focus areas of e-Mobility, Clean Energy and Automation) and deepening and expanding partnerships with leading OEMs reinforce our conviction in the target model of low double-digit sales growth and above 32% operating margin.”


Allegro has not provided a reconciliation of its third fiscal quarter outlook for non-GAAP Gross Margin, non-GAAP Operating Expenses, non-GAAP Interest Expense and non-GAAP Diluted Earnings per Share because estimates of all of the reconciling items cannot be provided without unreasonable efforts. It is difficult to reasonably provide a forward-looking estimate between such forward-looking non-GAAP measures and the comparable forward-looking U.S. generally accepted accounting principles (“GAAP”) measures. Certain factors that are materially significant to Allegro’s ability to estimate these items are out of its control and/or cannot be reasonably predicted.

Earnings Webcast

A webcast will be held on Thursday, November 2, 2023 at 8:30 a.m., Eastern Time. Vineet Nargolwala, President and Chief Executive Officer, and Derek D’Antilio, Chief Financial Officer, will discuss Allegro’s business and financial results.

The webcast will be available on the Investor Relations section of the Company’s website at investors.allegromicro.com. A recording of the webcast will be posted in the same location shortly after the call concludes and will be available for at least 90 days.

About Allegro MicroSystems

Allegro MicroSystems is a leading global designer, developer, fabless manufacturer and marketer of sensor integrated circuits (“ICs”) and application-specific analog power ICs enabling emerging technologies in the automotive and industrial markets. Allegro’s diverse product portfolio provides efficient and reliable solutions for the electrification of vehicles, automotive ADAS safety features, automation for Industry 4.0 and power saving technologies for data centers and green energy applications.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. We intend such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical facts contained in this press release including statements regarding our future results of operations and financial position, business strategy, prospective products and the plans and objectives of management for future operations, including, among others, statements regarding the liquidity, growth and profitability strategies and factors affecting our business are forward-looking statements. These statements involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements.

Without limiting the foregoing, in some cases, you can identify forward-looking statements by terms such as “aim,” “may,” “will,” “should,” “expect,” “exploring,” “plan,” “anticipate,” “could,” “intend,” “target,” “project,” “would,” “contemplate,” “believe,” “estimate,” “predict,” “potential,” “seek,” or “continue” or the negative of these terms or other similar expressions, although not all forward-looking statements contain these words. No forward-looking statement is a guarantee of future results, performance, or achievements, and one should avoid placing undue reliance on such statements.

Forward-looking statements are based on our management’s current expectations, beliefs and assumptions and on information currently available to us. Such beliefs and assumptions may or may not prove to be correct. Additionally, such forward-looking statements are subject to a number of known and unknown risks, uncertainties and assumptions, and actual results may differ materially from those expressed or implied in the forward-looking statements due to various factors, including, but not limited to, those identified in Part II, Item 7. “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” and Part I, Item 1A. “Risk Factors” in our Annual Report on Form 10-K for the year ended March 31, 2023. These risks and uncertainties include, but are not limited to: downturns or volatility in general economic conditions; our ability to compete effectively, expand our market share and increase our net sales and profitability; our reliance on a limited number of third-party semiconductor wafer fabrication facilities and suppliers of other materials; our failure to adjust purchase commitments and inventory management based on changing market conditions or customer demand; shifts in our product mix or customer mix, which could negatively impact our gross margin; the risk that the expected benefits of acquisitions may not be realized or that integration of acquired businesses may not continue as rapidly as we anticipate; the cyclical nature of the analog semiconductor industry; any downturn or disruption in the automotive market; our ability to compensate for decreases in average selling prices of our products and increases in input costs; our ability to manage any sustained yield problems or other delays at our third-party wafer fabrication facilities or in the final assembly and test of our products; our ability to accurately predict our quarterly net sales and operating results; our ability to adjust our supply chain volume to account for changing market conditions and customer demand; our dependence on manufacturing operations in the Philippines; our reliance on distributors to generate sales; the effects of COVID-19 on our supply chain and customer demand; our ability to develop new product features or new products in a timely and cost-effective manner; our ability to manage growth; any slowdown in the growth of our end markets; the loss of one or more significant customers; our ability to meet customers’ quality requirements; uncertainties related to the design win process and our ability to recover design and development expenses and to generate timely or sufficient net sales or margins; changes in government trade policies, including the imposition of export restrictions and tariffs; our exposures to warranty claims, product liability claims and product recalls; our dependence on international customers and operations; the availability of rebates, tax credits and other financial incentives on end-user demands for certain products; risks, liabilities, costs and obligations related to governmental regulation and other legal obligations, including export control, privacy, data protection, information security, consumer protection, environmental and


occupational health and safety, anti-corruption and anti-bribery, and trade controls; the volatility of currency exchange rates; our ability to raise capital to support our growth strategy; our indebtedness may limit our flexibility to operate our business; our ability to effectively manage our growth and to retain key and highly skilled personnel; our ability to protect our proprietary technology and inventions through patents or trade secrets; our ability to commercialize our products without infringing third-party intellectual property rights; disruptions or breaches of our information technology systems or those of our third-party service providers; our principal stockholders have substantial control over us; the inapplicability of the “corporate opportunity” doctrine to any director or stockholder who is not employed by us; anti-takeover provisions in our organizational documents and under the General Corporation Law of the State of Delaware; our inability to design, implement or maintain effective internal control over financial reporting; changes in tax rates or the adoption of new tax legislation; the negative impacts of sustained inflation on our business; disruptions in the banking and financial sector that limit our or our partners’ ability to access capital and borrowings; the physical, transition and litigation risks presented by climate change; and other events beyond our control. Moreover, we operate in an evolving environment. New risk factors and uncertainties may emerge from time to time, and it is not possible for management to predict all risk factors and uncertainties.

You should read this press release and the documents that we reference completely and with the understanding that our actual future results may be materially different from what we expect. We qualify all of our forward-looking statements by these cautionary statements. All forward-looking statements speak only as of the date of this press release, and except as required by applicable law, we do not plan to publicly update or revise any forward-looking statements, whether as a result of any new information, future events, changed circumstances or otherwise.

This press release includes certain non-GAAP financial measures as defined by the Securities and Exchange Commission (“SEC”) rules. These non-GAAP financial measures are provided in addition to, and not as a substitute for or superior to measures of, financial performance prepared in accordance with GAAP. There are a number of limitations related to the use of these non-GAAP financial measures versus their nearest GAAP equivalents. For example, other companies may calculate non-GAAP financial measures differently or may use other measures to evaluate their performance, all of which could reduce the usefulness of the presented non-GAAP financial measures as tools for comparison.

This press release may not be reproduced, forwarded to any person or published, in whole or in part.


ALLEGRO MICROSYSTEMS, INC.

CONSOLIDATED STATEMENT OF OPERATIONS

(in thousands, except share and per share amounts)

 

 

Three-Month Period Ended

 

 

Six-Month Period Ended

 

 

September 29,
2023

 

 

September 23,
2022

 

 

September 29,
2023

 

 

September 23,
2022

 

 

(Unaudited)

 

 

(Unaudited)

 

 

(Unaudited)

 

 

(Unaudited)

 

Net sales

 

$

275,509

 

 

$

237,666

 

 

$

553,802

 

 

$

455,419

 

Cost of goods sold

 

 

116,006

 

 

 

105,644

 

 

 

236,349

 

 

 

205,023

 

Gross profit

 

 

159,503

 

 

 

132,022

 

 

 

317,453

 

 

 

250,396

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

Research and development

 

 

43,428

 

 

 

35,567

 

 

 

86,403

 

 

 

69,424

 

Selling, general and administrative

 

 

43,160

 

 

 

36,617

 

 

 

87,389

 

 

 

106,397

 

Total operating expenses

 

 

86,588

 

 

 

72,184

 

 

 

173,792

 

 

 

175,821

 

Operating income

 

 

72,915

 

 

 

59,838

 

 

 

143,661

 

 

 

74,575

 

Interest and other income (expense)

 

 

156

 

 

 

(752

)

 

 

(2,486

)

 

 

(3,241

)

Income before income taxes

 

 

73,071

 

 

 

59,086

 

 

 

141,175

 

 

 

71,334

 

Income tax provision

 

 

7,400

 

 

 

8,438

 

 

 

14,615

 

 

 

10,403

 

Net income

 

 

65,671

 

 

 

50,648

 

 

 

126,560

 

 

 

60,931

 

Net income attributable to non-controlling interests

 

 

54

 

 

 

34

 

 

 

93

 

 

 

70

 

Net income attributable to Allegro MicroSystems, Inc.

 

$

65,617

 

 

$

50,614

 

 

$

126,467

 

 

$

60,861

 

Net income per common share attributable to Allegro MicroSystems, Inc.:

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

0.34

 

 

$

0.26

 

 

$

0.66

 

 

$

0.32

 

Diluted

 

$

0.34

 

 

$

0.26

 

 

$

0.65

 

 

$

0.32

 

Weighted average shares outstanding:

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

 

192,431,094

 

 

 

191,284,631

 

 

 

192,214,210

 

 

 

190,959,616

 

Diluted

 

 

195,100,855

 

 

 

192,639,576

 

 

 

195,055,495

 

 

 

192,654,097

 

 

Supplemental Schedule of Total Net Sales

The following table summarizes total net sales by market within the Company’s unaudited consolidated statements of operations:

 

Three-Month Period Ended

 

 

Change

 

 

Six-Month Period Ended

 

 

Change

 

 

September 29,
2023

 

 

September 23,
2022

 

 

Amount

 

 

%

 

 

September 29,
2023

 

 

September 23,
2022

 

 

Amount

 

 

%

 

 

(Dollars in thousands)

 

 

(Dollars in thousands)

 

Automotive

 

$

205,936

 

 

$

157,398

 

 

$

48,538

 

 

 

31

%

 

$

395,634

 

 

$

307,047

 

 

$

88,587

 

 

 

29

%

Industrial

 

 

51,114

 

 

 

48,176

 

 

 

2,938

 

 

 

6

%

 

 

119,298

 

 

 

88,316

 

 

 

30,982

 

 

 

35

%

Other

 

 

18,459

 

 

 

32,092

 

 

 

(13,633

)

 

 

(42

)%

 

 

38,870

 

 

 

60,056

 

 

 

(21,186

)

 

 

(35

)%

Total net sales

 

$

275,509

 

 

$

237,666

 

 

$

37,843

 

 

 

16

%

 

$

553,802

 

 

$

455,419

 

 

$

98,383

 

 

 

22

%

 


ALLEGRO MICROSYSTEMS, INC.

CONSOLIDATED BALANCE SHEETS

(in thousands, except share and per share amounts)

 

 

September 29,

 

 

March 31,

 

 

2023
(Unaudited)

 

 

2023

 

Assets

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

Cash and cash equivalents

 

$

370,013

 

 

$

351,576

 

Restricted cash

 

 

8,418

 

 

 

7,129

 

Trade accounts receivable, net

 

 

118,947

 

 

 

111,290

 

Trade and other accounts receivable due from related party

 

 

741

 

 

 

13,494

 

Inventories

 

 

173,089

 

 

 

151,301

 

Prepaid expenses and other current assets

 

 

39,938

 

 

 

27,289

 

Current portion of related party note receivable

 

 

3,750

 

 

 

3,750

 

Total current assets

 

 

714,896

 

 

 

665,829

 

Property, plant and equipment, net

 

 

312,047

 

 

 

263,099

 

Deferred income tax assets

 

 

68,385

 

 

 

50,359

 

Goodwill

 

 

27,707

 

 

 

27,691

 

Intangible assets, net

 

 

51,677

 

 

 

52,378

 

Related party note receivable, less current portion

 

 

6,563

 

 

 

8,438

 

Equity investment in related party

 

 

25,474

 

 

 

27,265

 

Other assets

 

 

78,188

 

 

 

86,096

 

Total assets

 

$

1,284,937

 

 

$

1,181,155

 

Liabilities, Non-Controlling Interests and Stockholders' Equity

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

Trade accounts payable

 

$

62,603

 

 

$

56,256

 

Amount due to related party

 

 

3,041

 

 

 

9,682

 

Accrued expenses and other current liabilities

 

 

68,597

 

 

 

99,387

 

Total current liabilities

 

 

134,241

 

 

 

165,325

 

Obligations due under Senior Secured Credit Facilities

 

 

25,000

 

 

 

25,000

 

Other long-term liabilities

 

 

27,408

 

 

 

24,015

 

Total liabilities

 

 

186,649

 

 

 

214,340

 

Commitments and contingencies

 

 

 

 

 

 

Stockholders' Equity:

 

 

 

 

 

 

Preferred stock

 

 

 

 

 

 

Common stock

 

 

1,925

 

 

 

1,918

 

Additional paid-in capital

 

 

683,891

 

 

 

674,179

 

Retained earnings

 

 

436,782

 

 

 

310,315

 

Accumulated other comprehensive loss

 

 

(25,509

)

 

 

(20,784

)

Equity attributable to Allegro MicroSystems, Inc.

 

 

1,097,089

 

 

 

965,628

 

Non-controlling interests

 

 

1,199

 

 

 

1,187

 

Total stockholders' equity

 

 

1,098,288

 

 

 

966,815

 

Total liabilities, non-controlling interests and stockholders' equity

 

$

1,284,937

 

 

$

1,181,155

 

 


ALLEGRO MICROSYSTEMS, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands)

 

 

Three Months Ended

 

 

Six Months Ended

 

 

September 29,
2023

 

 

September 23,
2022

 

 

September 29,
2023

 

 

September 23,
2022

 

 

(Unaudited)

 

 

(Unaudited)

 

 

(Unaudited)

 

 

(Unaudited)

 

Cash flows from operating activities:

 

 

 

 

 

 

 

 

 

 

 

 

Net income

 

$

65,671

 

 

$

50,648

 

 

$

126,560

 

 

$

60,931

 

Adjustments to reconcile net income to net cash provided by operating activities:

 

 

 

 

 

 

 

 

 

 

 

 

Depreciation and amortization

 

 

15,080

 

 

 

12,207

 

 

 

29,353

 

 

 

24,125

 

Amortization of deferred financing costs

 

 

73

 

 

 

25

 

 

 

107

 

 

 

49

 

Deferred income taxes

 

 

(9,772

)

 

 

(8,647

)

 

 

(18,134

)

 

 

(16,431

)

Stock-based compensation

 

 

10,877

 

 

 

8,204

 

 

 

21,919

 

 

 

42,340

 

Loss on disposal of assets

 

 

43

 

 

 

253

 

 

 

43

 

 

 

250

 

Change in fair value of contingent consideration

 

 

 

 

 

(2,500

)

 

 

 

 

 

(2,700

)

Provisions for inventory and receivables reserves

 

 

4,239

 

 

 

(2,408

)

 

 

9,422

 

 

 

232

 

Change in fair value of marketable securities

 

 

(72

)

 

 

(28

)

 

 

3,579

 

 

 

3,458

 

Changes in operating assets and liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

Trade accounts receivable

 

 

2,676

 

 

 

10,238

 

 

 

(7,645

)

 

 

5,520

 

Accounts receivable - other

 

 

1,052

 

 

 

(168

)

 

 

(369

)

 

 

2,546

 

Inventories

 

 

(3,274

)

 

 

(12,440

)

 

 

(31,221

)

 

 

(17,328

)

Prepaid expenses and other assets

 

 

(7,305

)

 

 

3,632

 

 

 

(16,084

)

 

 

(9,470

)

Trade accounts payable

 

 

(15,736

)

 

 

4,853

 

 

 

2,695

 

 

 

8,928

 

Due (from) to related party

 

 

(3,990

)

 

 

(2,414

)

 

 

6,112

 

 

 

(5,681

)

Accrued expenses and other current and long-term liabilities

 

 

(12,832

)

 

 

(6,204

)

 

 

(29,944

)

 

 

(4,965

)

Net cash provided by operating activities

 

 

46,730

 

 

 

55,251

 

 

 

96,393

 

 

 

91,804

 

Cash flows from investing activities:

 

 

 

 

 

 

 

 

 

 

 

 

Purchases of property, plant and equipment

 

 

(31,191

)

 

 

(20,831

)

 

 

(76,101

)

 

 

(35,220

)

Acquisition of business, net of cash acquired

 

 

 

 

 

(19,728

)

 

 

 

 

 

(19,728

)

Proceeds from sale of marketable securities

 

 

6,204

 

 

 

 

 

 

16,175

 

 

 

 

Net cash used in investing activities

 

 

(24,987

)

 

 

(40,559

)

 

 

(59,926

)

 

 

(54,948

)

Cash flows from financing activities:

 

 

 

 

 

 

 

 

 

 

 

 

Loans made to related party

 

 

 

 

 

(7,500

)

 

 

 

 

 

(7,500

)

Loan made to affiliate

 

 

(4,000

)

 

 

 

 

 

(4,000

)

 

 

 

Receipts on related party note receivable

 

 

937

 

 

 

468

 

 

 

1,875

 

 

 

937

 

Payments for taxes related to net share settlement of equity awards

 

 

(1,669

)

 

 

 

 

 

(14,091

)

 

 

(9,606

)

Proceeds from issuance of common stock under employee stock purchase plan

 

 

 

 

 

1,573

 

 

 

1,899

 

 

 

1,573

 

Payment for debt issuance costs

 

 

 

 

 

 

 

 

(1,450

)

 

 

 

Net cash used in by financing activities

 

 

(4,732

)

 

 

(5,459

)

 

 

(15,767

)

 

 

(14,596

)

Effect of exchange rate changes on cash and cash equivalents and restricted cash

 

 

(901

)

 

 

(2,223

)

 

 

(974

)

 

 

(8,777

)

Net increase in cash and cash equivalents and restricted cash

 

 

16,110

 

 

 

7,010

 

 

 

19,726

 

 

 

13,483

 

Cash and cash equivalents and Restricted cash at beginning of period

 

 

362,321

 

 

 

296,272

 

 

 

358,705

 

 

 

289,799

 

Cash and cash equivalents and restricted cash at end of period:

 

$

378,431

 

 

$

303,282

 

 

$

378,431

 

 

$

303,282

 

 


Non-GAAP Financial Measures

In addition to the measures presented in our consolidated financial statements, we regularly review other measures, defined as non-GAAP financial measures by the SEC, to evaluate our business, measure our performance, identify trends, prepare financial forecasts and make strategic decisions. The key measures we consider are non-GAAP Gross Profit, non-GAAP Gross Margin, non-GAAP Operating Expenses, non-GAAP Operating Income, non-GAAP Operating Margin, non-GAAP Profit before Tax, non-GAAP Provision for Income Tax, non-GAAP Net Income and non-GAAP Basic and Diluted Earnings per Share, EBITDA, Adjusted EBITDA and Adjusted EBITDA margin (collectively, the “Non-GAAP Financial Measures”). These Non-GAAP Financial Measures provide supplemental information regarding our operating performance on a non-GAAP basis that excludes certain gains, losses and charges of a non-cash nature or that occur relatively infrequently and/or that management considers to be unrelated to our core operations, and in the case of non-GAAP Provision for Income Tax, management believes that this non-GAAP measure of income taxes provides it with the ability to evaluate the non-GAAP Provision for Income Taxes across different reporting periods on a consistent basis, independent of special items and discrete items, which may vary in size and frequency. These Non-GAAP Financial Measures are used by both management and our board of directors, together with the comparable GAAP information, in evaluating our current performance and planning our future business activities.

The Non-GAAP Financial Measures are supplemental measures of our performance that are neither required by, nor presented in accordance with GAAP. These Non-GAAP Financial Measures should not be considered as substitutes for GAAP financial measures such as gross profit, gross margin, net income or any other performance measures derived in accordance with GAAP. Also, in the future we may incur expenses or charges such as those being adjusted in the calculation of these Non-GAAP Financial Measures. Our presentation of these Non-GAAP Financial Measures should not be construed as an inference that future results will be unaffected by unusual or nonrecurring items. These non-GAAP Financial Measures exclude costs related to acquisition and related integration expenses, amortization of acquired intangible assets, stock-based compensation, restructuring actions, related party activities and other non-operational costs.

Non-GAAP Provision for Income Tax

In calculating non-GAAP Provision for Income Tax, we have added back the following to GAAP Income Tax Provision:

Tax effect of adjustments to GAAP results—Represents the estimated income tax effect of the adjustments to non-GAAP Profit before Tax described above and elimination of discrete tax adjustments.

 

 

Three-Month Period Ended

 

 

Six-Month Period Ended

 

 

September 29,
2023

 

 

June 30,
2023

 

 

September 23,
2022

 

 

September 29,
2023

 

 

September 23,
2022

 

 

(Dollars in thousands)

 

 

(Dollars in thousands)

 

Reconciliation of Non-GAAP Gross Profit

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

GAAP Gross Profit

 

$

159,503

 

 

$

157,950

 

 

$

132,022

 

 

$

317,453

 

 

$

250,396

 

Non-GAAP adjustments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Purchased intangible amortization

 

 

273

 

 

 

402

 

 

 

378

 

 

 

675

 

 

 

651

 

Stock-based compensation

 

 

946

 

 

 

2,606

 

 

 

1,124

 

 

 

3,552

 

 

 

1,956

 

Total Non-GAAP Adjustments

 

$

1,219

 

 

$

3,008

 

 

$

1,502

 

 

$

4,227

 

 

$

2,607

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-GAAP Gross Profit

 

$

160,722

 

 

$

160,958

 

 

$

133,524

 

 

$

321,680

 

 

$

253,003

 

Non-GAAP Gross Margin (% of net sales)

 

 

58.3

%

 

 

57.8

%

 

 

56.2

%

 

 

58.1

%

 

 

55.6

%

 


 

 

Three-Month Period Ended

 

 

Six-Month Period Ended

 

 

September 29,
2023

 

 

June 30,
2023

 

 

September 23,
2022

 

 

September 29,
2023

 

 

September 23,
2022

 

 

(Dollars in thousands)

 

 

(Dollars in thousands)

 

Reconciliation of Non-GAAP Operating Expenses

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

GAAP Operating Expenses

 

$

86,588

 

 

$

87,204

 

 

$

72,184

 

 

$

173,792

 

 

$

175,821

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Research and Development Expenses

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

GAAP Research and Development Expenses

 

 

43,428

 

 

 

42,975

 

 

 

35,567

 

 

 

86,403

 

 

 

69,424

 

Non-GAAP adjustments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Transaction-related costs

 

 

2

 

 

 

7

 

 

 

201

 

 

 

9

 

 

 

403

 

Stock-based compensation

 

 

3,602

 

 

 

2,868

 

 

 

1,711

 

 

 

6,470

 

 

 

2,839

 

Non-GAAP Research and Development Expenses

 

 

39,824

 

 

 

40,100

 

 

 

33,655

 

 

 

79,924

 

 

 

66,182

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Selling, General and Administrative Expenses

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

GAAP Selling, General and Administrative Expenses

 

 

43,160

 

 

 

44,229

 

 

 

39,117

 

 

 

87,389

 

 

 

109,097

 

Non-GAAP adjustments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Transaction-related costs

 

 

1,804

 

 

 

3,072

 

 

 

63

 

 

 

4,876

 

 

 

1,660

 

Purchased intangible amortization

 

 

357

 

 

 

358

 

 

 

23

 

 

 

715

 

 

 

45

 

Restructuring costs

 

 

 

 

 

 

 

 

90

 

 

 

 

 

 

4,372

 

Stock-based compensation

 

 

6,329

 

 

 

5,568

 

 

 

5,369

 

 

 

11,897

 

 

 

37,545

 

Other costs

 

 

100

 

 

 

 

 

 

 

 

 

100

 

 

 

 

Non-GAAP Selling, General and Administrative Expenses

 

 

34,570

 

 

 

35,231

 

 

 

33,572

 

 

 

69,801

 

 

 

65,475

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Change in fair value of contingent consideration

 

 

 

 

 

 

 

 

(2,500

)

 

 

 

 

 

(2,700

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total Non-GAAP Adjustments

 

 

12,194

 

 

 

11,873

 

 

 

4,957

 

 

 

24,067

 

 

 

44,164

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-GAAP Operating Expenses

 

$

74,394

 

 

$

75,331

 

 

$

67,227

 

 

$

149,725

 

 

$

131,657

 

 

 

Three-Month Period Ended

 

 

Six-Month Period Ended

 

 

September 29,
2023

 

 

June 30,
2023

 

 

September 23,
2022

 

 

September 29,
2023

 

 

September 23,
2022

 

 

(Dollars in thousands)

 

 

(Dollars in thousands)

 

Reconciliation of Non-GAAP Operating Income

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

GAAP Operating Income

 

$

72,915

 

 

$

70,746

 

 

$

59,838

 

 

$

143,661

 

 

$

74,575

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Transaction-related costs

 

 

1,806

 

 

 

3,079

 

 

 

(2,236

)

 

 

4,885

 

 

 

(637

)

Purchased intangible amortization

 

 

630

 

 

 

760

 

 

 

401

 

 

 

1,390

 

 

 

696

 

Restructuring costs

 

 

 

 

 

 

 

 

90

 

 

 

 

 

 

4,372

 

Stock-based compensation

 

 

10,877

 

 

 

11,042